Carsten-henning H. Ohlmann

Kirrberger Street 100
Homburg, SL 66421, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Comparison of biparametric and multiparametric prostate MRI to assess extraprostatic tumor extension.

Comparison of biparametric and multiparametric prostate MRI to assess extraprostatic tumor extension.

Journal: European journal of radiology

Published: May 22, 2026

External validation of the P-Score in the prospective, pre-biopsy DEPROMP cohort: integrated mpMRI and PSMA PET/CT risk stratification for prostate cancer detection.

External validation of the P-Score in the prospective, pre-biopsy DEPROMP cohort: integrated mpMRI and PSMA PET/CT risk stratification for prostate cancer detection.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 18, 2026

Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial.

Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: September 24, 2025

Poly (ADP-ribose) polymerase inhibitor combination therapy in metastatic castration-resistant prostate cancer

Poly (ADP-ribose) polymerase inhibitor combination therapy in metastatic castration-resistant prostate cancer

Journal: Urologie (Heidelberg, Germany)

Published: September 10, 2025

Low heterogeneity of tumor grades in multiple MRI-targeted prostate biopsies argues for the aggregate method of grading.

Low heterogeneity of tumor grades in multiple MRI-targeted prostate biopsies argues for the aggregate method of grading.

Journal: Virchows Archiv : an international journal of pathology

Published: April 03, 2025

Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER Study.

Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER Study.

Journal: Advances in therapy

Published: November 05, 2024

Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer.

Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer.

Journal: World journal of urology

Published: May 16, 2024

Role of local treatments in prostate cancer

Role of local treatments in prostate cancer

Journal: Urologie (Heidelberg, Germany)

Published: January 15, 2024

Hormone-sensitive prostate cancer

Hormone-sensitive prostate cancer

Journal: Urologie (Heidelberg, Germany)

Published: February 08, 2023

Multimodal treatment strategies for urologic cancers

Multimodal treatment strategies for urologic cancers

Journal: Urologie (Heidelberg, Germany)

Published: October 14, 2022

Reply to RE: Should LHRH therapy be continued in patients receiving Abiraterone Acetate?

Reply to RE: Should LHRH therapy be continued in patients receiving Abiraterone Acetate?

Journal: Prostate cancer and prostatic diseases

Published: August 22, 2022

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer.

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer.

Journal: Cancers

Published: July 18, 2022

Showing 1-12 of 42

Last Updated: 09/26/2026